AI-assisted heart tracing tests for chest pain without blocked arteries
Tests AI-assisted heart rhythm recordings to detect chest pain caused by coronary artery problems.
Key facts
- Who runs it
- UMC Utrecht
- Where
- Utrecht, NetherlandsSee the site
- Trial code
- Registry title
- Artificial Intelligence in ANOCA
- Status
- Recruiting
- People taking part
- 250 people, planned
- Started
- 3 Dec 2024
- Expected to end
- Dec 2028
- Type of study
- Interventional
- Treatments tested
- Holter monitoring, intracoronary ECG
- Record updated
- 12 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with ongoing chest discomfort who have no blocked heart arteries needing a procedure. They are having a coronary function test.
- Age
- 18 years and older
- Sex
- All sexes can join
- Disease stage
- Chest discomfort (angina) at least 2 times per week despite current medicine, with no obstructive coronary artery disease that needs revascularization, shown on a recent CCTA scan or invasive coronary angiography
- Earlier treatment
- Must still have chest discomfort despite current medical therapy
Main reasons for not taking part
- No chest discomfort after starting medical therapy
- Language barrier that prevents enough understanding and communication in Dutch
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Clinical indication for comprehensive coronary function testing because of persisting chest discomfort at least 2 times per week despite current medical therapy
- Absence of obstructive coronary artery disease with an indication for revascularization, documented by means of recent coronary computed tomography angiography (CCTA) or invasive coronary angiography (with invasive coronary pressure measurements if clinically indicated)
- Patient is willing and able to provide written informed consent
Who cannot take part
- Absence of chest discomfort after initiation of medical therapy
- Language barrier preventing sufficient understanding and communication in Dutch
Where in Netherlands
- UMC UtrechtUtrecht, NetherlandsContact: Tim P. van de Hoef, M.D., Ph.D.Taking people
About the trial
What the trial wants to find out
Angina pectoris is diagnosed in >180.000 people in the Netherlands each year. Diagnosis in angina pectoris focuses on epicardial coronary stenosis, the identification of which may lead to guideline-directed medical therapy or revascularization. However, no such stenosis is identified in 40-70% of patients. This condition, angina with no obstructed coronary artery (ANOCA), is more prevalent in women and is related to poor quality of life, high medical expenses, and a higher incidence of adverse events.
Read full original descriptionShow less
The origin of ANOCA can be evaluated during invasive coronary angiography by coronary function testing (CFT) to identify coronary vasomotor disorders. This relates to vasospasm of the coronary artery and microcirculation, or to impaired microvascular vasodilation. For the diagnosis of vasospasm, CFT needs to result in electrocardiographic signs of myocardial ischemia as part of the diagnostic criteria. This is a critical point in the diagnosis of vasospasm, as these signs can be subtle and can vary, and are therefore prone to misinterpretation. Apart from this caveat, the diagnosis approach therefore currently requires an invasive procedure for the diagnosis. This limits the broad application and hampers early identification and treatment of ANOCA.
During CFT, a coronary guide wire is routinely advanced in the coronary artery which also allows obtaining an intracoronary ECG by attaching a sterile alligator clamp to a standard electrocardiogram lead. This allows continuous recording of intracoronary ECG throughout CFT on the same monitor as the routine ECG. This technique can increase sensitivity for myocardial ischemia during CFT. Further, Holter ECG monitoring allows the identification of ischemic changes in the ECG in the outpatient setting. Evidence is lacking on the patterns of myocardial ischemia that occur during spontaneous angina pectoris symptoms in ANOCA patients, and on the sensitivity of Holter ECG for this purpose. Finally, the interpretation of ischemic patterns on ECG tracings can be cumbersome, especially when changes are subtle or change from beat to beat. The use of deep learning techniques allows to automate the interpretation of ECG traces and may improve the standardized diagnosis in ANOCA.
The group in the trial
- Single armTreatment being tested
Intracoronary ECG and Holter ECG monitoring
Treatment: Holter monitoring, intracoronary ECG
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Artificial Intelligence-assisted Diagnostics In Angina With No Obstructive Coronary Artery Disease
- Plain-language title
- AI-assisted heart tracing tests for chest pain without blocked arteriesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 12 January 2026